AI-generated summary
The authors reviewed 33 journal articles and clinical trials on 595-nm pulsed dye laser treatment of pediatric port-wine birthmarks and infantile hemangiomas, including 7725 patients. They report that permanent adverse effects were uncommon, and that most studies reported good or better clearance. The authors describe the laser as an excellent option for early intervention.
- Participants
- 7,725
- Studies included
- 33
- Who or what was studied
- Pediatric patients with port-wine birthmarks or infantile hemangiomas
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The abstract does not describe study quality, certainty of evidence, or how outcomes were measured across the included studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Wavelength, Laser, Systematic review. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.